MEDomics has started using a new test called MitoDx to detect any and all mutations in any of the 37 identified mitochondrial genes. You can read more about it here. This is supposed to be a new way to help do early detection of mitochondrial disorders that do not require as invasive of testing (as the usual muscle biopsy). While it does detect mutations, it may not identify all with mitochondrial disease or dysfunction as there may be genes not yet identified that affect the mitochondria.
“To my knowledge, MEDomics is the first laboratory to offer a whole genome clinical diagnostic test utilizing the powerful NextGen sequencing technique” says Steve S Sommer, MD, PhD, Founder and President of MEDomics. (For more on the test itself, go here .)
It looks promising! I’m going to ask our mito doctor about it for our daughter.